23andMe Holding Co (NASDAQ: ME)’s stock price has dropped by -1.62 in relation to previous closing price of 0.40. Nevertheless, the company has seen a loss of -18.72% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-05 that SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company, will present data on its two clinical stage programs, 23ME-01473 targeting ULBP6, and 23ME-00610 targeting CD200R1, at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place in San Diego, CA, April 5-10, 2024.
Is It Worth Investing in 23andMe Holding Co (NASDAQ: ME) Right Now?
ME has 36-month beta value of 1.34. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ME is 280.60M, and currently, short sellers hold a 11.72% ratio of that float. The average trading volume of ME on April 16, 2024 was 6.58M shares.
ME’s Market Performance
ME stock saw a decrease of -18.72% in the past week, with a monthly decline of -10.97% and a quarterly a decrease of -40.46%. The volatility ratio for the week is 8.50%, and the volatility levels for the last 30 days are 9.96% for 23andMe Holding Co (ME). The simple moving average for the past 20 days is -16.76% for ME’s stock, with a -58.57% simple moving average for the past 200 days.
Analysts’ Opinion of ME
Many brokerage firms have already submitted their reports for ME stocks, with Berenberg repeating the rating for ME by listing it as a “Buy.” The predicted price for ME in the upcoming period, according to Berenberg is $7 based on the research report published on November 29, 2022 of the previous year 2022.
Cowen, on the other hand, stated in their research note that they expect to see ME reach a price target of $6. The rating they have provided for ME stocks is “Outperform” according to the report published on September 22nd, 2022.
Citigroup gave a rating of “Neutral” to ME, setting the target price at $13 in the report published on November 15th of the previous year.
ME Trading at -29.55% from the 50-Day Moving Average
After a stumble in the market that brought ME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.52% of loss for the given period.
Volatility was left at 9.96%, however, over the last 30 days, the volatility rate increased by 8.50%, as shares sank -16.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.04% lower at present.
During the last 5 trading sessions, ME fell by -18.72%, which changed the moving average for the period of 200-days by -77.03% in comparison to the 20-day moving average, which settled at $0.4709. In addition, 23andMe Holding Co saw -56.75% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ME starting from HIBBS KATHY L, who sale 38,548 shares at the price of $0.50 back on Apr 04 ’24. After this action, HIBBS KATHY L now owns 1,252,315 shares of 23andMe Holding Co, valued at $19,282 using the latest closing price.
HIBBS KATHY L, the Chief Administrative Officer of 23andMe Holding Co, sale 38,548 shares at $0.46 during a trade that took place back on Mar 21 ’24, which means that HIBBS KATHY L is holding 1,252,315 shares at $17,894 based on the most recent closing price.
Stock Fundamentals for ME
Current profitability levels for the company are sitting at:
- -2.17 for the present operating margin
- 0.45 for the gross margin
The net margin for 23andMe Holding Co stands at -2.1. The total capital return value is set at -1.16. Equity return is now at value -92.53, with -63.93 for asset returns.
Based on 23andMe Holding Co (ME), the company’s capital structure generated 0.17 points at debt to capital in total, while cash flow to debt ratio is standing at -2.33. The debt to equity ratio resting at 0.21. The interest coverage ratio of the stock is 118.62.
Currently, EBITDA for the company is -287.51 million with net debt to EBITDA at 1.77. When we switch over and look at the enterprise to sales, we see a ratio of 0.09. The receivables turnover for the company is 10.32for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.07.
Conclusion
To put it simply, 23andMe Holding Co (ME) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
